Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin. [electronic resource] by
- Espinel-Ingroff, A
- Arthington-Skaggs, B
- Iqbal, N
- Ellis, D
- Pfaller, M A
- Messer, S
- Rinaldi, M
- Fothergill, A
- Gibbs, D L
- Wang, A
Producer: 20070725
In:
Journal of clinical microbiology vol. 45
Availability: No items available.
|
|
32.
|
|
|
33.
|
Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi. [electronic resource] by
- Espinel-Ingroff, A
- Canton, E
- Fothergill, A
- Ghannoum, M
- Johnson, E
- Jones, R N
- Ostrosky-Zeichner, L
- Schell, W
- Gibbs, D L
- Wang, A
- Turnidge, J
Producer: 20110926
In:
Journal of clinical microbiology vol. 49
Availability: No items available.
|
|
34.
|
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. [electronic resource] by
- Pfaller, M A
- Diekema, D J
- Gibbs, D L
- Newell, V A
- Bijie, H
- Dzierzanowska, D
- Klimko, N N
- Letscher-Bru, V
- Lisalova, M
- Muehlethaler, K
- Rennison, C
- Zaidi, M
Producer: 20090202
In:
Journal of clinical microbiology vol. 47
Availability: No items available.
|